GE HealthCare Technologies R&D increased by 7.1% to $345.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $344.00M to $345.00M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 11.5% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $204.00M | $204.00M | $204.00M | $238.00M | $257.00M | $260.00M | $271.00M | $270.00M | $298.00M | $322.00M | $315.00M | $324.00M | $327.00M | $316.00M | $344.00M | $344.00M | $302.00M | $292.00M | $322.00M | $345.00M |
| QoQ Change | — | +0.0% | +0.0% | +16.7% | +8.0% | +1.2% | +4.2% | -0.4% | +10.4% | +8.1% | -2.2% | +2.9% | +0.9% | -3.4% | +8.9% | +0.0% | -12.2% | -3.3% | +10.3% | +7.1% |
| YoY Change | — | — | — | — | +26.0% | +27.5% | +32.8% | +13.4% | +16.0% | +23.8% | +16.2% | +20.0% | +9.7% | -1.9% | +9.2% | +6.2% | -7.6% | -7.6% | -6.4% | +0.3% |
Range$204.00M – $345.00M
CAGR+11.7%
Avg YoY Growth+11.1%
Median YoY Growth+11.6%
Current Streak2 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's r&d?
- GE HealthCare Technologies (GEHC) reported r&d of $345.00M in Q1 2026.
- How has GE HealthCare Technologies's r&d changed year-over-year?
- GE HealthCare Technologies's r&d increased by 0.3% year-over-year, from $344.00M to $345.00M.
- What is the long-term trend for GE HealthCare Technologies's r&d?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's r&d has grown at a 11.5% compound annual growth rate (CAGR), from $816.00M to $1.26B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.